As of 2025-10-27, the Relative Valuation of Harpoon Therapeutics Inc (HARP) is (2.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.01 USD, the upside of Harpoon Therapeutics Inc based on Relative Valuation is -111.1%.
The range of the Relative Valuation is (2.91) - (1.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.8x - 1.3x | 1.0x |
| Forward P/E multiples | 2.0x - 3.1x | 2.6x |
| Fair Price | (2.91) - (1.80) | (2.57) |
| Upside | -112.6% - -107.8% | -111.1% |
| Date | P/E |